Finance

Beta
Lists
TARA:NASDAQ
Protara Therapeutics Inc
$3.98
-2.21%
(-0.090) 1D
$3.98
0.00% (0.00)
After hours
Closed: Jun 18, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TARA...
Open
$4.10
High
$4.20
Low
$3.97
Mkt. cap
223.69M
Avg. vol.
755.80K
Volume
803.71K
52-wk high
$7.82
52-wk low
$2.77
EPS
-$1.35
Beta
1.45
Shares outstanding
56.20M
No. of employees
46
Open
$4.10
High
$4.20
Low
$3.97
Mkt. cap
223.69M
Avg. vol.
755.80K
Volume
803.71K
52-wk high
$7.82
52-wk low
$2.77
EPS
-$1.35
Beta
1.45
Shares outstanding
56.20M
No. of employees
46
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to TARA in the past 3 months
Strong Buy
Buy
7
Hold
0
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for TARA in the last 3 months.
Highest
Current $3.98
$28.00 (+603.52%)
Average
$26.00 (+553.27%)
Lowest
$24.00 (+503.02%)
News stories
From sources across the web
About Protara Therapeutics Inc
CEO-
Employees46
Founded2006
Headquarters-
SectorBiotechnology
Websiteprotaratx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10.77M
9.59M
13.12M
13.56M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.82M
5.17M
5.96M
6.07M
Operating expense
16.59M
14.76M
19.08M
19.63M
Total operating expenses
16.59M
14.76M
19.08M
19.63M
Operating income
-16.59M
-14.76M
-19.08M
-19.63M
Other non operating income
-
-
249.00K
-
EBT including unusual items
-14.96M
-13.26M
-17.31M
-17.78M
EBT excluding unusual items
-14.96M
-13.26M
-17.31M
-17.78M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14.96M
-13.26M
-17.31M
-17.78M
Net profit margin
-
-
-
-
Earnings per share
-0.35
-0.31
-0.38
-0.31
Interest and investment income
1.63M
1.50M
1.52M
1.85M
Interest expense
-
-
-
-
Net interest expenses
1.63M
1.50M
1.52M
1.85M
Depreciation and amortization charges
-
-
-
-
EBITDA
-16.49M
-14.67M
-18.99M
-19.54M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer